🇺🇸 FDA
Pipeline program

Tocilizumab

TACTIC-SS

Approved mab active

Quick answer

Tocilizumab for Takayasu Arteritis is a Approved program (mab) at Shanghai Zhongshan Hospital with 1 ClinicalTrials.gov record(s).

Program details

Company
Shanghai Zhongshan Hospital
Indication
Takayasu Arteritis
Phase
Approved
Modality
mab
Status
active

Clinical trials